Heather McArthur, MD, MPH, FASCO
@hmcarthur
Followers
3K
Following
2K
Media
41
Statuses
743
Clinical Director of Breast Oncology and Komen Distinguished Chair in Clinical Breast Cancer Research at UTSouthwestern
Dallas, TX
Joined April 2009
RT @utswcancer: .@hmcarthur joins experts in an @OncLive discussion on #ASCO25 updates in HER2-positive metastatic breast cancer, covering….
0
1
0
RT @OncLive: @hmcarthur and colleagues discuss the role of the CLEOPATRA regimen (docetaxel, trastuzumab, and pertuzuma as first-line trea….
0
1
0
RT @OncLive: ICYMI: @hmcarthur of @UTSWMedCenter discusses the expanding clinical role for ADCs like T-DXd in HER2-positive breast cancer.….
0
1
0
RT @utswcancer: As a panelist in @CancerNetwrk's latest discussion, @hmcarthur, Clinical Director of our Breast Cancer Program, shares expe….
0
1
0
RT @TargetedOnc: During a live event, Heather L. McArthur, MD, MPH, reviewed genomic assays for early-stage breast cancer. #bcsm | @hmcarth….
0
1
0
RT @CancerNetwrk: Starting June 9th at 5 PM EDT/4 PM CDT, catch.@VKaklamani and @hmcarthur discussing key breast cancer trials following #A….
0
1
0
RT @OncEd: ASCO dropped the data, now our experts help you take it from podium to practice. Watch now for concise recaps of top trials from….
0
4
0
RT @MedscapeLIVE: 🚨 If you're as serious about breast cancer care as @DrReshmaMahtani, @baik_alan, @antgiorda, @DrSGraff, @claudine_isaacs,….
0
8
0
0
5
0
RT @DrSGraff: My poster neighbors—.“The study was negative, but the friendship was positive” @hmcarthur @MIgnatiadis #ASCO25 .
0
9
0
RT @montypal: Love that @ConquerCancerFd managed to capture in the video below this simply magical moment when @AlexisLevee won her @ASCO Y….
0
10
0
RT @OncLive: Hear @ErikaHamilton9 of @SarahCannonDocs, @hmcarthur of @UTSWMedCenter, and @DrKEMcCann of @UCLA discuss sequencing for HER2+….
0
4
0
RT @PTarantinoMD: What is the cause of ADC-related ILD? Spoiler: most likely not the antibody target (e.g. not HER2). New data confirms pri….
0
72
0
RT @VKaklamani: Discussing adjuvant therapy as well as post mastectomy radiation. And who better to talk about all this than this panel @s….
0
7
0
RT @ErikaHamilton9: TDXd + pertuzumab improves PFS in 1st line DB-09! . #HER2.#bcsm.@OncoAlert .@OncBrothers .
0
11
0
Congratulations @AlexisLevee! Such a pleasure to collaborate with you!! Looking forward to celebrating your many future successes!!.
Thank you @OncoDaily for the opportunity to share my story! #TNBC #gutmicrobiome #breastcancer research @hmcarthur @montypal.
1
4
13
RT @AriellaHanker: 🙌Hey @utswcancer @UTSWMedCenter @UTSWCancerBio @UTSWHemeOnc @UTSWScience @UTSW_Pathology @UTSWMolBiol @utswimmuno don't….
0
2
0
RT @DFCI_BreastOnc: New📰in @TAMedOncol👉TROPION-Breast04: A randomized phase III study of neoadjuvant datopotamab deruxtecan (#DatoDXd) plus….
0
10
0
RT @TargetedOnc: Breakthroughs in TNBC: Immunotherapy & immune checkpoint inhibitors are revolutionizing treatment, enabling personalized p….
0
3
0
RT @EMJReviews: Discover how personalised care is on a path to revolutionise breast cancer treatment in the latest episode of Onc Now. Ho….
0
1
0